---
title: "18:22 ETAre KALV, GBTG, MDV, CPRX Obtaining Fair Deals for their Shareholders?"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286972817.md"
description: "Halper Sadeh LLC is investigating potential violations of federal securities laws by KalVista Pharmaceuticals, Global Business Travel Group, Modiv Industrial, and Catalyst Pharmaceuticals regarding their proposed sales. The firm is advocating for shareholders' rights and may seek increased compensation or disclosures. Shareholders are encouraged to contact the firm for legal options at no cost."
datetime: "2026-05-19T22:23:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286972817.md)
  - [en](https://longbridge.com/en/news/286972817.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286972817.md)
---

# 18:22 ETAre KALV, GBTG, MDV, CPRX Obtaining Fair Deals for their Shareholders?

**_Insiders may stand to receive substantial financial benefits not available to ordinary shareholders._**

**_The proposed transactions may contain terms that could limit superior competing offers._**

**_Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses._**

, /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

**KalVista Pharmaceuticals, Inc. (NASDAQ: KALV)'s** sale to Chiesi Group for $27.00 per share in cash. **If you are a KalVista shareholder,** **click here to learn more about your legal rights and options**.

**Global Business Travel Group, Inc. (NYSE: GBTG)'s** sale to Long Lake Management for $9.50 per share in cash. **If you are a Global Business shareholder,** **click here to learn more about your rights and options****.**

**Modiv Industrial, Inc. (NYSE: MDV)'s** sale to Global Net Lease, Inc. Upon closing of the proposed transaction, Modiv shareholders are expected to own approximately 11% of the combined company. **If you are a Modiv shareholder,** **click here to learn more about your legal rights and options**.

**Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX)'s** sale to Angelini Pharma S.p.A. for $31.50 per share in cash. **If you are a Catalyst shareholder,** **click here to learn more about your rights and options****.**

On behalf of shareholders, Halper Sadeh LLC may seek increased consideration, additional disclosures and information, or other relief and benefits.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:  
Halper Sadeh LLC  
Daniel Sadeh, Esq.  
Zachary Halper, Esq.  
One World Trade Center  
85th Floor  
New York, NY 10007  
(212) 763-0060  
\[email protected\]  
\[email protected\]  
https://www.halpersadeh.com

SOURCE Halper Sadeh LLP

### Related Stocks

- [CPRX.US](https://longbridge.com/en/quote/CPRX.US.md)
- [KALV.US](https://longbridge.com/en/quote/KALV.US.md)
- [GBTG.US](https://longbridge.com/en/quote/GBTG.US.md)
- [MDV.US](https://longbridge.com/en/quote/MDV.US.md)
- [GNL.US](https://longbridge.com/en/quote/GNL.US.md)
- [MDV-A.US](https://longbridge.com/en/quote/MDV-A.US.md)
- [GNL-A.US](https://longbridge.com/en/quote/GNL-A.US.md)
- [GNL-E.US](https://longbridge.com/en/quote/GNL-E.US.md)
- [GNL-D.US](https://longbridge.com/en/quote/GNL-D.US.md)
- [GNL-B.US](https://longbridge.com/en/quote/GNL-B.US.md)

## Related News & Research

- [Merger Agreement With Chiesi Puts Strategic Handcuffs on KalVista, Raising Execution and Liquidity Risks](https://longbridge.com/en/news/286635514.md)
- [Full Transcript: DRI HEALTHCARE TRUST Q1 2026 Earnings Call](https://longbridge.com/en/news/286578500.md)
- [Family-Run Angelini Pharma Buys Catalyst Pharmaceuticals For Over 4 Billion](https://longbridge.com/en/news/285584437.md)
- [<![CDATA[Angelini Pharma Enters $ 4.1 Billion Agreement to Acquire Catalyst Pharmaceuticals ]]>](https://longbridge.com/en/news/285566381.md)
- [GNL reaffirms $0.80-$0.84 AFFO per share guidance while targeting Q3 close for Modiv deal](https://longbridge.com/en/news/285655865.md)